Download PDF
1 / Pages

Other users also viewed these articles

Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;
Reumatol Clin. 2020;16P1:345-52
Ultrasound tenosynovitis: A differential feature of patients with seronegative rheumatoid arthritis Santiago Ruta; Einer Sanchez Prado; Facundo Salvatori; Juan Arguello; Darío Aguerre; Sebastián Magri; Rodrigo García Salinas;
Reumatol Clin. 2023;19:63-6
Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5